RxDoctor Payments Data

Kristina Samson, PA

Physician Assistant · Radford, VANPI 1477960391

Payments from drug & device makers

$1,729in general payments, 2019–2025

Across 97 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$370
  • AbbVie$309
  • AstraZeneca$198
  • Pfizer$133
  • Astellas Pharma US Inc$114
  • Exact Sciences$108
  • plus $497 from 16 others

What the payments were for

  • Food & beverage$1,729100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,729 in reported general payments places this provider in the 80th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$48,039
Medicare patients
148
Services billed
819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide66$71,078
OzempicSemaglutide67$62,859
JanuviaSitagliptin Phosphate58$45,020
EliquisApixaban44$44,442
JardianceEmpagliflozin32$40,685
FarxigaDapagliflozin Propanediol43$32,730
LinzessLinaclotide33$23,038
QuliptaAtogepant12$12,899
RybelsusSemaglutide12$12,406
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,620
Sucralfate29$4,627
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$4,188
SynthroidLevothyroxine Sodium39$3,628
Venlafaxine Hcl ErVenlafaxine Hcl32$2,585
Levothyroxine Sodium236$1,965

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$370$75,26579 claims
Lilly USA, LLCTrulicity$101$71,07866 claims
PfizerEliquis$133$44,44244 claims
AstraZenecaFarxiga, Breztri Aerosphere$198$42,35056 claims
Boehringer IngelheimJardiance$17$40,68532 claims
AbbVieLinzess, Qulipta, Synthroid$309$39,56584 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Radford

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →